Please login to the form below

Not currently logged in
Email:
Password:

BARDA

This page shows the latest BARDA news and features for those working in and with pharma, biotech and healthcare.

J&J could launch its single-dose COVID-19 vaccine in March

J&J could launch its single-dose COVID-19 vaccine in March

The phase 3 ENSEMBLE trial was launched in collaboration with the US Department of Health and Human Services’ (HHS) Biomedical Advanced Research and Development Authority (BARDA) and the US National Institute

Latest news

More from news
Approximately 2 fully matching, plus 29 partially matching documents found.

Latest Intelligence

  • Rethinking our approach to infectious disease preparedness Rethinking our approach to infectious disease preparedness

    Achaogen and Aradigm filed for bankruptcy in 2019, and Melinta did the same at the start of 2020, despite heavy investment from the US Biomedical Advanced Research and Development Authority (BARDA). ... Commendably, BARDA provided funding to bridge the

  • Developing a COVID-19 vaccine Developing a COVID-19 vaccine

    That includes an agreement with the US Biomedical Advanced Research and Development Authority (BARDA) on the development of a recombinant, protein-based vaccine candidate.

  • Biotech profile: Tom Evans, CEO, Vaccitech.

    US agencies like BARDA have a long history of supporting these innovative approaches to public health. ... We are conducting a 134-person influenza challenge study, one of the largest ever conducted and co-funded by BARDA,  to validate this approach.

  • Deal Watch September 2016 Deal Watch September 2016

    BARDA) has been very busy announcing grants with a range of companies for various development projects. ... The Medicines Co received a BARDA grant of up to $132m for the development of antibiotics against drug-resistant, gram-negative infections.

  • Deal Watch June 2016 Deal Watch June 2016

    BARDA) to support Cerus' clinical development programme for pathogen reduction of red blood cell (RBC) components. ... collaboration, licence. 200. Cerus/ BARDA. Intercept, pathogen reduction technology for blood transfusions including Zika virus.

More from intelligence
Approximately 0 fully matching, plus 7 partially matching documents found.

Latest from PMHub

  • What is everyone ‘ARPAing on about?

    On Wednesday 16th September, Ursula Von Der Leyen, President of the European Union, announced in her State of Union address that they plan to develop BARDA, a Biomedical Advanced Research and ... But can DARPA, ARPA or BARDA actually deliver

  • Hanover Communications Hanover Communications

    On Wednesday 16th September, Ursula Von Der Leyen, President of the European Union, announced in her State of Union address that they plan to develop BARDA, a Biomedical Advanced Research and ... But can DARPA, ARPA or BARDA actually deliver

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Market Access Transformation

Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...

Latest intelligence

Emre Vural
Sourcing R&D innovation: why pharma companies need to evolve their business models
Recent years have seen a significant shift in drug development to specialty areas...
2020 - a year to remember or forget?
2020 and the Covid pandemic brought immense challenges, and the need for change felt like it happened overnight. What have we learned and what does the future of agency working...
Gilead Headquarters
The search for effective drug treatments for COVID-19
PME talks to Julian Cole, Senior Director, Medical Affairs at Gilead Sciences...

Infographics